FDA slaps down J&J on Ertaczo ad; Roche, Lilly drugs run short in U.K.;

> Johnson & Johnson used a misleading medical journal advertisement to promote its Ertaczo athlete's foot cream, FDA says. Report

> Amid shortages of many drugs in the U.K., the two drugs most difficult to obtain are Roche's weight loss drug Xenical and Eli Lilly's antipsychotic med Zyprexa, pharmacists said in a poll. Report

> ViroPharma said it was not aiming to be acquired, responding to a market rumor that Teva Pharmaceutical Industries was looking to buy the company. Report

> Stolen vials of Novo Nordisk insulin for diabetics may still be on the market and may be harmful, FDA warned. Report

> Cardinal Health announced a cash tender offer to purchase up to $1.2 billion of its long-term debt securities as part of a plan to reduce its long-term debt. Release

> Mylan launched its version of Sanofi-Aventis' skin drug BenzaClin, the first generic to hit the market. Report

> Aurobindo Pharma won the FDA nod for its version of Pharmacia & Upjohn's Cleocin antibiotic. Report

Biotech News

> Shares of Nymox spiked dramatically this morning, soaring 59 percent on the news that its experimental therapy for a common type of liver cancer proved highly effective in animal studies. Report

> Endo Pharmaceuticals has handed out a $10 million upfront payment for the U.S. licensing rights to ProStrakan's testosterone replacement therapy Fortesta. News

> Shares of Human Genome Sciences hit $19.20--a seven-year high--after reports surfaced yesterday that the market has been buzzing about an upcoming buyout offer from GlaxoSmithKline. The Telegraph lit the market fire with an item about Glaxo's rumored $30-a-share bid for HGS. Report

> Researchers for Japan's Dainippon Sumitomo say that a second late-stage trial offered convincing data that their experimental drug lurasidone controls symptoms for schizophrenia without some of the serious side affects that afflict some patients taking competing drugs. Report

Vaccine News

> The same HPV vaccines used to guard against cervical cancer in girls and young women could also protect men from a rare penile cancer. Report

> Backed with funds from the Bill and Melinda Gates Foundation, a group of researchers say they're ready to launch human trials of a new inhalable measles vaccine that can be used to guard against the disease in poor countries. Report

> Faced with alarming projections that swine flu can kill up to 90,000 Americans, U.S. government officials have given vaccine makers a green light to start preparing shipments of a new jab--their fill-and-finish stage--before they even have clinical trial data in hand. News

And Finally ... Though typhoid fever is a rare disease in the United States, the proportion of cases caused by drug-resistant Salmonella typhi is increasing. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.